Literature DB >> 17532221

The 1,4-naphthoquinone scaffold in the design of cysteine protease inhibitors.

Cláudia Valente1, Rui Moreira, Rita C Guedes, Jim Iley, Mohammed Jaffar, Kenneth T Douglas.   

Abstract

A series of 1,4-naphthoquinone derivatives diversely substituted at C-2, C-3, C-5 and C-8, prepared by reaction of amines, amino acids and alcohols with commercial 1,4-naphthoquinones, has been evaluated against papain and bovine spleen cathepsin B. These 1,4-naphthoquinone derivatives were found to be irreversible inhibitors for both cysteine proteases, with second-order rate constants, k(2), ranging from 0.67 to 35.4M(-1)s(-1) for papain, and from 0.54 to 8.03M(-1)s(-1) for cathepsin B. Some derivatives display a hyperbolic dependence of the first-order inactivation rate constant, k(obs), with the inhibitor concentration, indicative of a specific interaction process between enzyme and inhibitor. The chemical reactivity of the compounds towards cysteine as a model thiol is dependent on the naphthoquinone LUMO energy, whereas papain inactivation is not. The 1,4-naphthoquinone derivatives are inactive against the serine protease, porcine pancreatic elastase.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17532221     DOI: 10.1016/j.bmc.2007.04.068

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  9 in total

1.  Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries.

Authors:  Thung-S Lai; Yusha Liu; Tim Tucker; Kurt R Daniel; David C Sane; Eric Toone; James R Burke; Warren J Strittmatter; Charles S Greenberg
Journal:  Chem Biol       Date:  2008-09-22

2.  Trimer hydroxylated quinone derived from apocynin targets cysteine residues of p47phox preventing the activation of human vascular NADPH oxidase.

Authors:  Mauricio Mora-Pale; Seok Joon Kwon; Robert J Linhardt; Jonathan S Dordick
Journal:  Free Radic Biol Med       Date:  2011-12-29       Impact factor: 7.376

3.  Cysteine 81 is critical for the interaction of S100A4 and myosin-IIA.

Authors:  Natalya G Dulyaninova; Karen M Hite; Wendy D Zencheck; Dominic A Scudiero; Steven C Almo; Robert H Shoemaker; Anne R Bresnick
Journal:  Biochemistry       Date:  2011-07-21       Impact factor: 3.162

4.  Structure-activity relationship study of vitamin k derivatives yields highly potent neuroprotective agents.

Authors:  Benjamin J Josey; Elizabeth S Inks; Xuejun Wen; C James Chou
Journal:  J Med Chem       Date:  2013-01-30       Impact factor: 7.446

5.  Novel quercetin derivatives in treatment of peroxynitrite-oxidized SERCA1.

Authors:  Petronela Žižková; Dušan Blaškovič; Magdaléna Májeková; L'ubomír Švorc; Lucia Račková; L'ubica Ratkovská; Miroslav Veverka; L'ubica Horáková
Journal:  Mol Cell Biochem       Date:  2013-10-19       Impact factor: 3.396

6.  The synthesis of highly functionalised pyridines using Ghosez-type reactions of dihydropyrazoles.

Authors:  Federica Catti; Paula S Kiuru; Alexandra M Z Slawin; Nicholas J Westwood
Journal:  Tetrahedron       Date:  2008-09-29       Impact factor: 2.457

7.  Naphthoquinones as Covalent Reversible Inhibitors of Cysteine Proteases-Studies on Inhibition Mechanism and Kinetics.

Authors:  Philipp Klein; Fabian Barthels; Patrick Johe; Annika Wagner; Stefan Tenzer; Ute Distler; Thien Anh Le; Paul Schmid; Volker Engel; Bernd Engels; Ute A Hellmich; Till Opatz; Tanja Schirmeister
Journal:  Molecules       Date:  2020-04-28       Impact factor: 4.411

8.  Synthesis of thia-Michael-Type Adducts between Naphthoquinones and N-Acetyl-L-Cysteine and Their Biological Activity.

Authors:  Gabriele Micheletti; Carla Boga; Chiara Zalambani; Giovanna Farruggia; Erika Esposito; Jessica Fiori; Nicola Rizzardi; Paola Taddei; Michele Di Foggia; Natalia Calonghi
Journal:  Molecules       Date:  2022-09-01       Impact factor: 4.927

9.  Evaluation of SARS-CoV-2 3C-like protease inhibitors using self-assembled monolayer desorption ionization mass spectrometry.

Authors:  Zachary A Gurard-Levin; Cheng Liu; Andreas Jekle; Ruchika Jaisinghani; Suping Ren; Koen Vandyck; Dirk Jochmans; Pieter Leyssen; Johan Neyts; Lawrence M Blatt; Leonid Beigelman; Julian A Symons; Pierre Raboisson; Michael D Scholle; Jerome Deval
Journal:  Antiviral Res       Date:  2020-09-05       Impact factor: 5.970

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.